Analystreport

Akero Therapeutics (NASDAQ: AKRO) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating.

Akero Therapeutics, Inc.  (AKRO) 
Last akero therapeutics, inc. earnings: 3/16 07:30 am Check Earnings Report